Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Benitec Biopharma (BNTC) Preferred Dividend Payments (2023 - 2025)

Benitec Biopharma (BNTC) has disclosed Preferred Dividend Payments for 2 consecutive years, with $619.0 million as the latest value for Q1 2025.

  • Quarterly Preferred Dividend Payments changed N/A to $619.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $619.0 million through Jun 2025, up 99897.9% year-over-year, with the annual reading at $619000.0 for FY2024, N/A changed from the prior year.
  • Preferred Dividend Payments hit $619.0 million in Q1 2025 for Benitec Biopharma, up from $619000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $619.0 million in Q1 2025 to a low of $619000.0 in Q3 2023.